IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -95.05% | -93.89% | -73.68% | -70.05% | -54.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -95.05% | -93.89% | -73.68% | -70.05% | -54.55% |
| Cost of Revenue | 6.27% | -96.18% | -79.65% | -74.04% | 56.08% |
| Gross Profit | -84.15% | -86.18% | -52.20% | -58.97% | -279.26% |
| SG&A Expenses | -46.27% | -48.16% | -36.21% | -28.56% | -46.44% |
| Depreciation & Amortization | 179.17% | -195.88% | 172.95% | 12.35% | 59.49% |
| Other Operating Expenses | 9.43% | -44.51% | -24.33% | -4.14% | -13.05% |
| Total Operating Expenses | 2.64% | -46.74% | -27.98% | -26.77% | -27.72% |
| Operating Income | -11.58% | 40.12% | 18.91% | 19.51% | 23.59% |
| Income Before Tax | 21.64% | 119.33% | 10.79% | 25.07% | 22.29% |
| Income Tax Expenses | -913.33% | -- | 106.67% | -- | 141.67% |
| Earnings from Continuing Operations | 24.36% | 119.35% | 10.40% | 25.12% | 21.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.36% | 119.35% | 10.40% | 25.12% | 21.60% |
| EBIT | -11.58% | 40.12% | 18.91% | 19.51% | 23.59% |
| EBITDA | -12.71% | 40.08% | 30.01% | 20.23% | 26.42% |
| EPS Basic | 60.23% | 116.29% | 20.49% | 37.42% | 15.38% |
| Normalized Basic EPS | 59.09% | 93.94% | 20.99% | 37.63% | 15.38% |
| EPS Diluted | 60.23% | 114.33% | 23.67% | 35.48% | 15.38% |
| Normalized Diluted EPS | 58.72% | 93.90% | 20.56% | 38.86% | 16.15% |
| Average Basic Shares Outstanding | 89.17% | 17.54% | 12.81% | 19.76% | -7.66% |
| Average Diluted Shares Outstanding | 88.36% | 17.09% | 12.86% | 22.17% | -7.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |